On May 16, 2-014, the Securities and Exchange Commission (“Commission”) announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange Act”), of trading in the securities of FusionPharm, In...
http://www.securitieslawyer101.com/fusion-pharm/
No comments:
Post a Comment